
Northrop Grumman (NOC) Stock Forecast & Price Target
Northrop Grumman (NOC) Analyst Ratings
Bulls say
Northrop Grumman is well positioned by a record $109.6B backlog, a 1.5x book-to-bill, and 3Q26 results that topped expectations with adj. EPS of $7.89, sales of $11.1B, and adj. FCF of $1.81B. The outlook is supported by broad-based program strength, with Aeronautics and Defense Systems growing 14% and 12%, FY27 base-budget support for key programs like B-21 and Sentinel, and management guiding to 2027 sales growth of 5%–7% with 10–20 bps of margin expansion. Confidence is further reinforced by improving execution and cash generation, with all four segments expected to grow in 2027, core programs largely funded, and 2027 FCF guided to $3.3B–$3.7B despite higher capex.
Bears say
Northrop Grumman is viewed negatively because its growth profile appears only in line with peers, with roughly 6% top-line growth through 2028 and limited margin expansion, which makes a valuation premium harder to justify. The loss of the F/A-XX Navy fighter jet removes a major upside catalyst, leaving the B-21, space portfolio, and solid rocket motor business to drive growth, but each likely requires incremental investment and may pressure near-term sentiment and margins. In addition, slower post-FY27 defense budget growth, limited international exposure, rising F-35 risk, and reduced share repurchase support weaken catalysts for EPS and free cash flow expansion.
This aggregate rating is based on analysts' research of Northrop Grumman and is not a guaranteed prediction by Public.com or investment advice.
Northrop Grumman (NOC) Analyst Forecast & Price Prediction
Start investing in Northrop Grumman (NOC)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Northrop Grumman (NOC) Forecast
Northrop Grumman (NOC) Analyst Forecast & Price Prediction
Start investing in Northrop Grumman (NOC)
Order type
Buy in
Order amount
Est. shares
0 shares